Clinical Trial Update: Varenicline and Bupropion for Smoking Cessation [Phase 2, Phase 3]

View source ↗

Summary

A Mayo Clinic phase 2/3 clinical trial evaluating varenicline and bupropion for smoking cessation has completed and results were posted in April 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tobacco Use Disorder

Drugs mentioned

• Varenicline (varenicline)
• bupropion (bupropion)

Snippet

Sponsor: Mayo Clinic | Conditions: Smoking | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2014-04-24